Oncolytic viruses

E Antonio Chiocca - Nature Reviews Cancer, 2002 - nature.com
Although the cytotoxic effects of viruses are usually viewed in terms of pathogenicity, it is
possible to harness this activity for therapeutic purposes. Viral genomes are highly versatile …

[PDF][PDF] Adenovirus and cell cycle control

H Ben-Israel, T Kleinberger - Front Biosci, 2002 - researchgate.net
Introduction 3. The E1A proteins 3.1. Early findings 3.2. Targeting the pRb checkpoint by
E1A 3.2. 1. pRb 3.2. 2. pRb family members 3.3. Targeting cyclin-Cdks by E1A 3.4. E1A …

STAT3/5 inhibitors suppress proliferation in bladder cancer and enhance oncolytic adenovirus therapy

SV Hindupur, SC Schmid, JA Koch, A Youssef… - International Journal of …, 2020 - mdpi.com
The JAK-STAT signalling pathway regulates cellular processes like cell division, cell death
and immune regulation. Dysregulation has been identified in solid tumours and STAT3 …

A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases

P Sova, XW Ren, S Ni, KM Bernt, J Mi, N Kiviat… - Molecular Therapy, 2004 - cell.com
We have constructed a new capsid-modified adenovirus (Ad) vector that specifically
replicates in tumor cells and expresses TNF-related apoptosis-inducing ligand (TRAIL). The …

Molecular regulation and biological function of adenovirus early genes: the E4 ORFs

B Täuber, T Dobner - Gene, 2001 - Elsevier
Over the past few years there have been a number of interesting advances in our
understanding of the functions encoded by the adenovirus early transcription unit 4 (Ad E4) …

Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer

M Yamamoto, J Davydova, M Wang, GP Siegal… - Gastroenterology, 2003 - Elsevier
Background & aims: Pancreatic cancer is one of the most aggressive human malignancies.
Conditionally replicative adenoviruses (CRAds) have shown some promise in the treatment …

Fiber knob modifications overcome low, heterogeneous expression of the coxsackievirus-adenovirus receptor that limits adenovirus gene transfer and oncolysis for …

TP Cripe, EJ Dunphy, AD Holub, A Saini, NH Vasi… - Cancer research, 2001 - AACR
Exploiting the lytic life cycle of viruses has gained recent attention as an anticancer strategy
(oncolysis). To explore the utility of adenovirus (Ad)-mediated oncolysis for …

Oncolytic virotherapy for cancer treatment: challenges and solutions

JJ Davis, B Fang - The Journal of Gene Medicine: A cross …, 2005 - Wiley Online Library
Advances in gene modification and viral therapy have led to the development of a variety of
vectors in several viral families that are capable of replication specifically in tumor cells …

Adenoviral vectors armed with PAPILLOMAVIRUs oncogene specific CRISPR/Cas9 kill human-papillomavirus-induced cervical cancer cells

E Ehrke-Schulz, S Heinemann, L Schulte, M Schiwon… - Cancers, 2020 - mdpi.com
Human papillomaviruses (HPV) cause malignant epithelial cancers including cervical
carcinoma, non-melanoma skin and head and neck cancer. They drive tumor development …

Survivin interacts with Smac/DIABLO in ovarian carcinoma cells but is redundant in Smac-mediated apoptosis

IA McNeish, R Lopes, SJ Bell, TR McKay… - Experimental cell …, 2005 - Elsevier
Abnormalities in the control and execution of apoptosis are seen in many malignancies,
including ovarian carcinoma. Many of these abnormalities involve the mitochondrial …